A novel test could identify myeloma patients who have a lower chance of survival and unlikely to benefit from lenalidomide, British researchers have announced.
A team from the Institute of Cancer Research (ICR) in London examined...
13 days ago
The charity Bloodwise has issued guidance about the coronavirus COVID-19 aimed at blood cancer patients, setting out those at greatest risk and what measures should be taken.
Many haematology patients who have blood cancers suffe...
13 days ago